GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathwayZhigu Liu(Sun Yat-sen University), Wen Xu(Soochow University)Cellular and Molecular Life SciencesOctober 30, 202510.1007/s00018-025-05844-0Cited by 5SaveCiteExport RISWatch citationsRelated PapersComparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)|Journal of Internal Medicine|2014|59